OPY vs XRAY · P/E 13, rev $1.43B vs rev $3.68B
Oppenheimer Holdings Inc (OPY) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
OPY currently screens at market cap $1.15B and trailing P/E 12.8. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the OPY and XRAY stock pages for the full models.
Not investment advice.